Boston Institute of Biotechnology

Biotechnology ResearchMassachusetts, United States11-50 Employees

The Boston Institute of Biotechnology is a biotechnology research organization and contract development and manufacturing organization (CDMO) based at 225 Turnpike Road, 1st Floor, Southborough, Massachusetts, United States. It provides full-spectrum services for microbial expression systems, mammalian expression systems, gene therapy and cell therapy, and operates a 6,000-square-foot facility with isolated laboratories for cell culture, fermentation, purification, and analytical services. The company is located in the Genetown area within the Metro-Boston region and offers flexible, adaptable lab spaces to meet client needs. Its mission emphasizes trust and long-term partnerships, delivering robust bioprocess solutions on time and aligning client success with its own. Boston Institute of Biotechnology supports strain and cell line development from DNA to clone selection and stability, and develops scalable microbial fermentation and mammalian cell culture processes for the production of therapeutic proteins and antibodies, leveraging experience with various mammalian cell lines and microorganisms. Recent activity includes a 2024 Global Biologics CDMO Technology Leadership Award and the launch of a new generation of high-efficiency cell culture production technology, with annual revenue in the range of $10M-$25M.

Sign up for free to view info

Email Format Employee directory